SCHEMBL3936014

SCHEMBL3936014

COc1ccc2nc(-c3cc(OC)c(OC)c(OC)c3)cc(C(=O)O)c2c1.COc1ccc2nc(-c3cc(OC)c(OC)c(OC)c3)cc(C(=O)O)c2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.68
PLA2G2A P14555 6/20 0.64
HSD17B10 Q99714 3/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
ALDH1A1 P00352 3/20 0.60
LMNA P02545 3/20 0.60
MAPT P10636 3/20 0.60
HPGD P15428 2/20 0.60
POLB P06746 2/20 0.60
TP53 P04637 1/20 0.60
RAB9A P51151 2/20 0.58
NPC1 O15118 1/20 0.58
NFKB1 P19838 1/20 0.58
NFKB2 Q00653 1/20 0.58
RELA Q04206 1/20 0.58
ATM Q13315 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
CYP2D6 P10635 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3935413 1.00 KDM4E (0.68) KDM4EPLA2G2AHSD17B10SMN1; SMN2MEN1
SCHEMBL3941759 0.93 KDM4E (0.60) KDM4EPLA2G2AHSD17B10SMN1; SMN2MEN1
SCHEMBL13963644 0.91 PLA2G2A (0.59) KDM4EPLA2G2AHSD17B10SMN1; SMN2MEN1
SCHEMBL3936021 0.90 PLA2G2A (0.65) KDM4EPLA2G2AHSD17B10SMN1; SMN2MEN1
SCHEMBL13963326 0.90 PLA2G2A (0.58) KDM4EPLA2G2AHSD17B10SMN1; SMN2MEN1
SCHEMBL4602262 0.90 KDM4E (0.68) KDM4EPLA2G2AHSD17B10SMN1; SMN2MEN1
SCHEMBL13958696 0.88 PLA2G2A (0.59) KDM4EPLA2G2AHSD17B10SMN1; SMN2MEN1
SCHEMBL4602317 0.88 KDM4E (0.66) KDM4EHSD17B10SMN1; SMN2MEN1KMT2A
SCHEMBL3937571 0.86 KDM4E (0.64) KDM4EHSD17B10SMN1; SMN2MEN1KMT2A
SCHEMBL4600479 0.86 DHODH (0.64) KDM4EPLA2G2AHSD17B10SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009013354-A1 ARYLMETHYLENE SUBSTITUTED N-ACYL-β-AMINO ALCOHOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-01-29 WO disclosed